Development of a Smallpox Antiviral

Abstract

This contract, NDA-Enabling Development for SIGA-246: A Smallpox Antiviral, supports the advanced development of ST-246, a smallpox drug candidate, through the preparation and filing of a New Drug Application with the Food and Drug Administration.

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Institute of Allergy and Infectious Diseases (NIAID)
Type: Research and Development Contracts (N01)
Project #: N01AI60014-4-0-1
Application #: 7693583
Study Section

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year: 2008
Total Cost: $11,484,928
Indirect Cost

Institution

Name: Siga Technologies, Inc.
Department
Type
DUNS #: 932651516

City: Corvallis
State: OR
Country: United States
Zip Code: 97333

Related projects


NIH 2008 N01 AI	Development of a Smallpox Antiviral / Siga Technologies, Inc.	$11,484,928
NIH 2007 N01 AI	Development of Therapeutic Agent for Selected Viral Disaeses Hruby, Dennis E. /	$8,348,051
NIH 2007 N01 AI	Development of a Smallpox Antiviral /
NIH 2007 N01 AI	Development of a Smallpox Antiviral /

Comments

Be the first to comment on this grant